Amiron National Healthcare Pvt. Ltd. को ब्रान्ड परिवार हो, नेपालमा बिक्री हुन्छ। NepalDoc सूचीमा यसका २ वटा उत्पादन छन्, सबै Amiodarone Hydrochloride।
Amiodarone Hydrochloride Injection, USP is indicated for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation (VF) and hemodynamically unstable ventricular tachycardia (VT) in patients refractory to other therapy. Amiodarone Hydrochloride Injection, USP also can be used to treat patients with VT/VF for whom oral amiodarone is indicated, but who are unable to take oral medication.
From the U.S. FDA-approved label for Amiodarone Hydrochloride. Full label: DailyMed.
Amiodarone Hydrochloride Injection, USP is indicated for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation (VF) and hemodynamically unstable ventricular tachycardia (VT) in patients refractory to other therapy. Amiodarone Hydrochloride Injection, USP also can be used to treat patients with VT/VF for whom oral amiodarone is indicated, but who are unable to take oral medication. During or after treatment with Amiodarone Hydrochloride Injection, USP patients may be transferred to oral amiodarone therapy. Use Amiodarone Hydrochloride Injection, USP for acute treatment until the patient's ventricular arrhythmias are stabilized. Most patients will require this therapy for 48 to 96 hours, but Amiodarone Hydrochloride Injection may be safely administered for longer periods if necessary.
From the U.S. FDA-approved label for Amiodarone Hydrochloride. Full label: DailyMed.
Amiodarone shows considerable interindividual variation in response. Although a starting dose adequate to suppress life-threatening arrhythmias is needed, close monitoring with adjustment of dose is essential. The recommended starting dose of amiodarone is about 1000 mg over the first 24 hours of therapy, delivered by the following infusion regimen: After the first 24 hours, continue the maintenance infusion rate of 0.5 mg/min (720 mg per 24 hours) utilizing a concentration of 1 to 6 mg/mL (Use a central venous catheter for amiodarone concentrations greater than 2 mg/mL).
Directions from the U.S. FDA-approved label for Amiodarone Hydrochloride — your doctor or pharmacist may advise differently.
Amiodarone is contraindicated in patients with: Known hypersensitivity to any of the components of amiodarone, including iodine. Hypersensitivity reactions may involve rash, angioedema, cutaneous/mucosal hemorrhage (bleeding), fever, arthralgias (joint pains), eosinophilia (abnormal blood counts), urticaria (hives), thrombotic thrombocytopenic purpura, or severe periarteritis (inflammation around blood vessels). Cardiogenic shock. Marked sinus bradycardia. Second- or third-degree atrio-ventricular (AV) block unless a functioning pacemaker is available.
Excerpt from the U.S. FDA-approved label for Amiodarone Hydrochloride. Talk to a pharmacist or doctor before use.
Amiodarone should be administered only by physicians who are experienced in the treatment of life-threatening arrhythmias, who are thoroughly familiar with the risks and benefits of amiodarone therapy, and who have access to facilities adequate for monitoring the effectiveness and side effects of treatment. 5.1 Hypotension Hypotension is the most common adverse reaction seen with intravenous amiodarone. In clinical trials, treatment-emergent, drug-related hypotension was reported as an adverse effect in 288 (16%) of 1836 patients treated with intravenous amiodarone.
Warnings and precautions excerpt from the U.S. FDA-approved label for Amiodarone Hydrochloride — not a complete list. Talk to a pharmacist or doctor before use.
6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
Excerpt from the U.S. FDA-approved label for Amiodarone Hydrochloride — not a complete list. Talk to a pharmacist or doctor about side effects.
१३ ब्रान्ड · ७ निर्माता — NepalDoc सूचीमा — पूरै Amiodarone Hydrochloride गाइड हेर्नुहोस् →
Protect from light and excessive heat. Protect contents from light until time of use.
Storage information from the U.S. FDA-approved label for Amiodarone Hydrochloride.
Amiron के हो?
Amiron 100mg Tablet भनेको Amiodarone Hydrochloride औषधि हो, National Healthcare Pvt. Ltd. ले बनाएको। यो 100mg Tablet रूपमा पाइन्छ।
Amiron को सामान्य नाम के हो?
Amiron को सामान्य नाम Amiodarone Hydrochloride हो।
नेपालमा Amiodarone Hydrochloride का कुन कुन ब्रान्ड उपलब्ध छन्?
NepalDoc सूचीमा Amiodarone Hydrochloride का १३ वटा ब्रान्ड छन्, ७ निर्माताबाट — जसमा Amidar 100mg Tablet, Amidar 200mg Tablet, Amiodar 100mg Tablet, Amiodar 200mg Tablet, Amiron 200mg Tablet, Cordarone 100mg Tablet पर्छन्।
Amiron को मूल्य नेपालमा कति हो?
NepalDoc ले औषधिको मूल्य सूचीबद्ध गर्दैन। मूल्य हरेक फार्मेसीले आफैं तय गर्छ र समयसँगै परिवर्तन हुन्छ — यो पृष्ठले नेपालमा बिक्री हुने ब्रान्ड, यसको सामान्य नाम, निर्माता, शक्ति र प्याक विवरण पुष्टि गर्छ, ताकि तपाईं आफ्नो फार्मेसीमा मूल्य विश्वस्त भएर सोध्न सक्नुहोस्।
यो पृष्ठ सामान्य जानकारीका लागि मात्र हो, चिकित्सकीय सल्लाह होइन। औषधिको विवरण माथि उल्लेखित स्रोतहरूबाट आएको हो र परिवर्तन हुन सक्छ — प्रयोग गर्नुअघि डाक्टर वा फार्मासिस्टसँग औषधि, शक्ति र मात्रा पुष्टि गर्नुहोस्। सूचीमा हुनुले कुनै फार्मेसीमा औषधि उपलब्ध छ भन्ने ग्यारेन्टी दिँदैन।
नेपालडकका सबै खण्ड, एकै ठाउँमा।